Evidence map›Paper›PMID 41376837›Full record

ArticleMetabolic engineering communications2025

Model-guided chemical environment and metabolic network design to couple pathways with cell fitness.

Natalia Kakko von Koch, Tuula Tenkanen, Sandra Castillo, Virve Vidgren, Tino Koponen, Kristoffer Krogerus, Merja Penttilä, Paula Jouhten

Abstract read
In one paragraph

Article in Metabolic engineering communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Natalia Kakko von KochAalto University, School of Chemical Engineering, Department of Bioproducts and Biosystems, Espoo, Finland.
Tuula TenkanenVTT Technical Research Centre of Finland Ltd, Espoo, Finland.
Sandra CastilloVTT Technical Research Centre of Finland Ltd, Espoo, Finland.
Virve VidgrenVTT Technical Research Centre of Finland Ltd, Espoo, Finland.
Tino KoponenVTT Technical Research Centre of Finland Ltd, Espoo, Finland.
Kristoffer KrogerusVTT Technical Research Centre of Finland Ltd, Espoo, Finland.
Merja PenttiläVTT Technical Research Centre of Finland Ltd, Espoo, Finland.
Paula JouhtenAalto University, School of Chemical Engineering, Department of Bioproducts and Biosystems, Espoo, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heterologous compound production is a complex trait since the native metabolic fluxes supplying the precursors, redox power, and energy are under multilevel cellular regulation. Improving complex traits using targeted engineering needs combinatorially charting the complex genetic underpinnings. While this is laborious, adaptive laboratory evolution (ALE) has been used to improve many traits of microbial strains that are of application relevance such as tolerance of harsh conditions and nutrient utilization. However, in contrast to such traits, heterologous production can seldom be intuitively coupled with cellular fitness. Here, a novel method EvolveXGA was developed for genome-scale metabolic model guided design of strategies combining chemical environments and genetic engineering of the metabolic network to allow ALE of desired traits. Adaptive evolution of traits occurs when the co-variance between the traits and fitness involves a genetic dependency like a flux coupling would indicate. Thus, combinations of chemical environments and metabolic network structures were searched using a genetic algorithm to identify those that render desired traits (i.e., sets of metabolic fluxes) flux-coupled with fitness. The search was performed for the production of 29 heterologous compounds in yeast

Indexed as

Adaptive laboratory evolutionGenetic algorithmGenome-scale metabolic modelGlycolic acid

Identifiers

PMID41376837
PMCPMC12686821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.